Aortic Valve Stenosis clinical trials

Explore recruiting aortic valve stenosis clinical trials.

Recruiting aortic valve stenosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Aortic Valve Stenosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Does Colchicine Reduce Progression of Aortic Valve Stenosis? Colchicine and Inflammation in Aortic Stenosis (CHIANTI): A placebo-controlled, double-blind, multicenter randomized trial.

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on the progression of calcific aortic valve stenosis [Lp(a)FRONTIERS CAVS]

Denmark, Italy, Netherlands, Portugal, Czechia, Austria +4 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Personalized, CT-guided antithrombotic therapy versus lifelong single antiplatelet therapy to reduce thromboembolic and bleeding events in non-atrial fibrillation patients after transcatheter aortic valve implantation: a pragmatic, international, multicentre, randomized clinical trial (POPular ATLANTIS trial)

Netherlands, France, Belgium, Denmark, Germany

Therapeutic use (Phase IV) EU CTIS Study details

IcoSApent ethyL to slow down aortic VAlve stenosis proGrEssion (SALVAGE)

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Effect of Dapagliflozin on myocardial and renal function following aortic valve stenosis intervention

Denmark

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 2b/3, Randomized, Double-Blinded, Placebo Controlled Study ChecKing the Efficacy and Safety of ATAciguat to Slow the Progression of VaLvular DYsfunction in Participants with Moderate Calcific Aortic Valve STenosis (KATALYST-AV)

Norway, Czechia, Portugal, Austria, Poland, France +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Aortic Valve Stenosis trials by city

Aortic Valve Stenosis in Toronto Aortic Valve Stenosis in Vancouver Aortic Valve Stenosis in Montreal Aortic Valve Stenosis in Calgary Aortic Valve Stenosis in Edmonton Aortic Valve Stenosis in Ottawa Aortic Valve Stenosis in Winnipeg Aortic Valve Stenosis in Quebec City Aortic Valve Stenosis in Hamilton Aortic Valve Stenosis in Kitchener Aortic Valve Stenosis in London Aortic Valve Stenosis in Halifax Aortic Valve Stenosis in New York Aortic Valve Stenosis in Los Angeles Aortic Valve Stenosis in Chicago Aortic Valve Stenosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease